Patients The forgotten few: Why the kidney transplant system is faili... While innovation has reshaped therapeutic areas like oncology, transplant medicine has, by comparison, stood still.
Digital Maternity care needs improvement, healthtech can help The Birth Trauma Inquiry collected evidence from 1,300 women and found that maternity care of “
Patients Navigating transplant networks: Ensuring equitable access an... Over three million people live with kidney disease in the UK. Some will progress to end-stage kidney disease, which is ultimately fatal, without either dialysis or kidney transplant.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.